Quantbot Technologies LP Vertex Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

$1.97 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $275,429 - $329,776	-803 Reduced 94.92%	43 $17,000
Q3 2023 Nov 07, 2023	BUY	$338.18 - $362.46 $92,323 - $98,951	273 Added 47.64%	846 $294,000
Q2 2023 Aug 08, 2023	BUY	$314.42 - $351.91 $180,162 - $201,644	573 New	573 $201,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $2.24 Million - $2.52 Million	7,826 New	7,826 $2.26 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $32,189 - $40,079	137 Added 34.16%	538 $151,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $88,789 - $104,648	401 New	401 $104,000
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $3.57 Million - $4.51 Million	-20,190 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $3.66 Million - $4.1 Million	20,190 New	20,190 $3.66 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $959,573 - $1.13 Million	-5,118 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $1.04 Million - $1.21 Million	5,034 Added 5992.86%	5,118 $1.1 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $1.19 Million - $1.58 Million	-5,739 Reduced 98.56%	84 $19,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $879,947 - $1.04 Million	3,442 Added 144.56%	5,823 $1.58 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $536,867 - $704,299	2,381 New	2,381 $691,000
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $1.95 Million - $2.41 Million	-9,743 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $477,457 - $641,278	2,864 Added 41.63%	9,743 $2.13 Million
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $1.34 Million - $1.51 Million	-8,049 Reduced 53.92%	6,879 $1.17 Million
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $1.03 Million - $1.19 Million	6,227 Added 71.57%	14,928 $2.74 Million
Q1 2019 May 13, 2019	SELL	$163.73 - $194.7 $317,308 - $377,328	-1,938 Reduced 18.22%	8,701 $1.6 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $1.62 Million - $2.04 Million	10,639 New	10,639 $1.76 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $4.15 Million - $4.77 Million	-24,762 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $356,139 - $415,382	2,444 Added 10.95%	24,762 $4.21 Million
Q1 2018 May 11, 2018	BUY	$151.6 - $177.13 $3.38 Million - $3.95 Million	22,318 New	22,318 $3.64 Million
Q4 2017 Feb 12, 2018	SELL	$137.28 - $155.55 $206,743 - $234,258	-1,506 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$148.13 - $162.24 $223,083 - $244,333	1,506	1,506 $228,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account